华厦眼科
(301267)
| 流通市值：69.05亿 | | | 总市值：176.40亿 |
| 流通股本：3.29亿 | | | 总股本：8.40亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,138,913,370 | 1,093,056,547.55 | 4,027,010,847.67 | 3,181,879,566.3 |
| 营业收入 | 2,138,913,370 | 1,093,056,547.55 | 4,027,010,847.67 | 3,181,879,566.3 |
| 二、营业总成本 | 1,754,338,135.17 | 890,717,629.48 | 3,453,876,046.72 | 2,626,338,758.9 |
| 营业成本 | 1,172,120,240.03 | 601,500,424.28 | 2,247,347,295.86 | 1,717,111,676.34 |
| 税金及附加 | 8,594,006.65 | 4,239,996.01 | 14,877,610.58 | 11,157,115.86 |
| 销售费用 | 275,239,552.81 | 136,115,187.56 | 582,150,388.51 | 450,517,487.58 |
| 管理费用 | 246,407,553.59 | 122,419,870.52 | 503,803,636.49 | 368,250,115.21 |
| 研发费用 | 30,524,125.84 | 15,539,755.73 | 70,631,994.27 | 53,903,578.99 |
| 财务费用 | 21,452,656.25 | 10,902,395.38 | 35,065,121.01 | 25,398,784.92 |
| 其中:利息费用 | 22,144,921.01 | 11,659,980.56 | 45,131,094.69 | 34,158,144.63 |
| 其中:利息收入 | 4,097,287.43 | 2,648,383.51 | 16,746,151.06 | 14,029,295.32 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,060,138.1 | 7,658,570.29 | -5,086,595.9 | 9,999,143.89 |
| 加:投资收益 | 21,854,808.39 | 7,508,769.79 | 70,849,092.93 | 45,033,384.18 |
| 资产处置收益 | 2,484,168.56 | 525,862.81 | 3,490,695.43 | 472,794.7 |
| 资产减值损失(新) | -1,590,220.58 | 0 | -14,220,191.65 | -1,145,683.85 |
| 信用减值损失(新) | -7,816,377.11 | -4,680,123.85 | -11,420,043.53 | -2,904,706.5 |
| 其他收益 | 7,164,725.8 | 5,951,452 | 27,703,150.6 | 24,028,314.59 |
| 四、营业利润 | 411,732,477.99 | 219,303,449.11 | 644,450,908.83 | 631,024,054.41 |
| 加:营业外收入 | 4,182,658.5 | 1,416,564.47 | 5,305,501.24 | 4,849,226.77 |
| 减:营业外支出 | 28,924,910.61 | 10,009,214.09 | 86,586,424.64 | 67,959,623.54 |
| 五、利润总额 | 386,990,225.88 | 210,710,799.49 | 563,169,985.43 | 567,913,657.64 |
| 减:所得税费用 | 86,662,527.38 | 45,412,291.54 | 134,954,846.31 | 125,579,194.94 |
| 六、净利润 | 300,327,698.5 | 165,298,507.95 | 428,215,139.12 | 442,334,462.7 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 300,327,698.5 | 165,298,507.95 | 428,215,139.12 | 442,334,462.7 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 281,963,516.79 | 149,673,716.87 | 428,640,508.53 | 420,861,349.22 |
| 少数股东损益 | 18,364,181.71 | 15,624,791.08 | -425,369.41 | 21,473,113.48 |
| 扣除非经常损益后的净利润 | 277,868,378.08 | 139,838,322.08 | 408,760,889.53 | 416,538,802.66 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.34 | 0.18 | 0.51 | 0.5 |
| (二)稀释每股收益 | 0.34 | 0.18 | 0.51 | 0.5 |
| 八、其他综合收益 | -616,422.35 | -197,544.67 | -819,868.32 | 104,416.5 |
| 归属于母公司股东的其他综合收益 | -616,422.35 | -197,544.67 | -804,687.84 | 104,416.5 |
| 九、综合收益总额 | 299,711,276.15 | 165,100,963.28 | 427,395,270.8 | 442,438,879.2 |
| 归属于母公司股东的综合收益总额 | 281,347,094.44 | 149,476,172.2 | 427,835,820.69 | 420,965,765.72 |
| 归属于少数股东的综合收益总额 | 18,364,181.71 | 15,624,791.08 | -440,549.89 | 21,473,113.48 |
| 公告日期 | 2025-08-25 | 2025-04-28 | 2025-04-28 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |